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A B S T R A C T   
We describe what is to our knowledge the first case of aneurysm regrowth and rupture after the nine years, of a 
complete occlusion of an aneurysm of the left middle cerebral treated of Leo Plus Stent.   
1. Introduction 
In this case report, we describe what is to our knowledge, the first 
case of aneurysm regrowth and rupture nine years after complete oc-
clusion of an aneurysm of the left middle cerebral artery treated with a 
LEO stent. 
Is a 52-year-old man was referred to our hospital for a partially 
thrombosed fusiform large aneurysm of the sphenoidal segment (M1) of 
the left middle cerebral artery 
(MCA). The aneurysm was diagnosed after the patient had under-
gone magnetic resonance imaging (MRI) at another institution because 
of acute-onset aphasia and right hemiparesis. The patient’s medical and 
family history was unremarkable, except that he smoked two packet of 
cigarettes per day. MRI examination revealed a partially thrombosed left 
MCA aneurysm and a subacute infarction in the left MCA territory 
(lenticulostriate branches). A digital subtraction angiography (DSA) was 
performed which showed presence of a large fusiform aneurysm (1.7 ×
1.5 × 1.4 cm) that extended over the M1segment of the left MCA 
(Fig. 1A). 
The patient gave his informed consent. Ethics approval was not 
required for these case reports.The patient was pre-treated for three days 
with aspirin 325 mgr/day and plavix 75 mgr/day. A Leo stent 3,5 X 25 
mm (Balt extrusion, Montmorency, France) 
was deployed easily in M1 over the neck of the aneurysm in a 
satisfactory position (Fig. 1B) .The patient was maintained on daily 
aspirin (200mgrs) and clopidogrel (75 mg) for 3 months after stenting, 
after which the patient switched to a single antiplatelet agent (aspirin 
100 mg) daily. 
The patient was discharged from hospital 7 days after treatment with 
no neurological deficit. A 6-month follow-up angiogram revealed almost 
complete occlusion of the aneurysm and patency of the left MCA 
(Fig. 2A). 1-year follow-up angiogram confirmed complete thrombosis 
of the fusiform aneurysm with preservation of parent vessel patency 
(Fig. 2B) . 
The subsequent angiographic and MRI follow-ups at 2, 4 and 6 years 
(Fig. 3A, 3B, 3C) showed complete occlusion of the aneurysm. The pa-
tient continues with his normal life, without performing any further 
clinical or radiological control. Despite counseling, the patient 
continued to smoke during the follow‑up period. 
At 9 year after treatment, the patient presented with intense head-
ache. TOF-MRA revealed recanalization and growth of the aneurysm 
with perilesional edema (Fig. 4A, 4B). Diffusion weighted imaging did 
not show any ischemic lesion. Thus it was planned to treat the aneurysm 
with a flow diverter device inside the stent. At 24 h the aneurysm 
ruptured and the patient died fatally . 
2. Discuss 
Leo stent (Balt Extrusion, Montmorency, France) is self-expanding 
closed-cell stents produced by braiding individual strands of nitinol 
onto a mandrel. Leo stents have a relatively small pore size (cell size of 
approximately 0.9 mm) that gives a higher metal coverage ratio 
compared with other self-expandable stents, allowing a certain grade of 
flow-diverting hemodynamic effect similar to those provided by 
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conventional flow-diverter devices, both on the aneurysm and covered 
side branches and perforators [1]. 
Leo stents have been successfully used as stent monotherapy, espe-
cially for distal and complex small aneurysms. The first experience of 
flow-diverter treatment with Leostents monotherapy was described by 
Pumar et al [2], reporting 75% complete occlusion after treatment of 20 
intracranial fusiform aneurysms. Aydin et al [3] and Canazzo et al [4]l 
reported 73% and 70% complete occlusion respectively. In none of these 
series was recanalization evident in the follow-ups at one year. 
Endovascular therapy is now the first-line treatment for the majority 
of cases of cerebral aneurysms. However, rates of aneurysm 
recanalization vary over a wide range from 17% to 90%.depending on 
various factors including treatment-related factors, initial [5,6] incom-
plete occlusion, stent-assisted coiling, and utilization of flow diversion 
devices that have been demonstrated to impact on aneurysm recanali-
zation rates. Given the risk of recanalization, assessment of aneurysm 
recurrence is critical following endovascular treatment. 
Compared with traditional embolization techniques, flow diverters 
have proved to be at least as safe, and provide adequate and stable oc-
clusion in the long term [7,8]. 
Occlusion rates of > 85%–90% at 6–12 months after PED placement 
have been reported in major series in the literature with low retreatment 
rates[7,8]. According to our knowledge no study in the literature has 
reported growth of an aneurysm after on‑label PED use alone. Lang et al 
[9] report of recurrence rapid regrowth at nine months, of a supraclinoid 
blister aneurysm, after a 6-months angiogram demonstrating complete 
occlusion after successful treatment with two flow diverting pipeline 
embolization devices (PED) deployed in a telescoping fashion. Chen et al 
[10], report aneurysm regrowth at 10 months, treated with two over-
lapping PED, after treatment with two overlapping PED, the initial fol-
low‑up angiography, at 4 months, showed near‑complete occlusion. 
Trivelato et al [11], report recanalization at 9 months of an aneurysm 
totally occluded on the control angiography at 6 months, after treatment 
treated with a PED and coils. Zhan et al [12], report a rare case of 
recurrence, at 2 year angiographic follow-up, of a large intracavernous 
aneurysm after angiography proved complete occlusion at 6 months, 
treated by a combination of a Tubridge flow diverter and coils, and 
balloon angioplasty. 
In our case , we believe that hemodynamic stress of unknown origin 
Fig. 1. (A) AP angiogram demonstrating a large 20 mm × 24 mm × 22 mm 
(width × depth × height) left M1 aneurysm. (B) AP Procedural angiogram 
showing a Leo stent (3.5 mm × 25 mm) place, with good aneurysm 
neck coverage. 
Fig. 2. (A) 6-month follow-up AP angiogram showing decrease in the size of the aneurysm. (B) 1-year follow-up AP angiogram and 3D angiogram (C) confirmed 
complete thrombosis of the fusiform aneurysm with preservation of patency of the parent vessel. 
Fig. 3. 2-year follow-up AP angiogram (A), 4-year follow-up AP angiogram (B), 6-year follow-up AP angiogram (C) showed a complete occlusion of the aneurysm.  
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at the lesion site, could have played a key role in the morphological 
changes 
The mechanism of recanalization is poorly understood. The organi-
zation and liquefaction of the thrombus and subsequent intrathrombotic 
dissection by blood flow could be one possible explanation. Collagen 
replacement of the fibrin matrix, the potential for angiogenesis and the 
generation of microvessels that may cause recanalization exists. Another 
mechanism that could explain the recurrent filling could be the demands 
of the perforators create inflow into the aneurysm through small neo-
intimal defects Nevertheless, a lenticulostriate artery arising from the 
M1 aneurysm was not identified. In our case, we believe that hemody-
namic stress of unknown origin at the lesion site, could have played a 
key role in the morphological changes 
The patient smoked, throughout the follow-up, two packet of ciga-
rettes per day. Smoking is a known risk factor of aneurysm development 
and may be associated with aneurysm regrowth following endovascular 
embolization. Smoking may preclude vessel remodeling and aneurysm 
sac clotting in the setting of flow diversion through its effects on vascular 
flow and collagen synthesis. In our case given the rarity of aneurysm 
regrowth after flow diversion, its risk factors may be difficult to identify. 
In general, there is no universally agreed upon timetable for imaging 
and clinical follow-up of treated aneurysms. We performed a typical 
follow-up regimen, imaging study at 3 to 6 months followed by a second 
study at 12 to 24 months, and again at 3- years concluding 5-years 
posttreatment, because data examining aneurysm recurrence beyond 
the 5-year mark were scan. 
In conclusion, although majority of recurrences occur within the first 
year after treatment, the recanalization at 9-year after complete occlu-
sion of our case suggests that longer follow-up should be considered in 
certain types of high-risk aneurysms. 
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Fig. 4. (A, B, C) At nine years TOF-MRA revealed recanalization and growth of the aneurysm with perilesional edema.  
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